How much funding has Amplicore raised?

Amplicore has raised $4.0M in total funding, most recently a Seed round.

Who are Amplicore's investors?

Amplicore's investors include Photon Fund, Berkeley Catalyst Fund.

Where is Amplicore headquartered?

Amplicore is headquartered in San Francisco, California, United States.

What industry is Amplicore in?

Amplicore operates in Healthcare.

Amplicore

San Francisco, United States · $4.0M raised

Healthcare

Headquarters: San Francisco, California
Website: amplicorepharma.com
Total Funding: $4.0M

Last Round: $4.0M SeedMar 2021
Rounds: 1

About

Amplicore is a San Francisco-based biopharmaceutical company developing injectable therapeutics for degenerative musculoskeletal disorders, including joint osteoarthritis, cartilage damage, degenerative disc disease, and acute meniscus tear. Unlike current treatments that only relieve pain, Amplicore takes a regenerative approach that addresses the underlying causes of joint discomfort. The company's mission is to translate scientific innovation into minimally invasive products that can be easily delivered to patients in need of restored mobility.

Summary

Amplicore is a Healthcare company based in San Francisco, United States. It has raised $4.0M in total across 1 round, most recently a $4.0M Seed round in Mar 2021. Investors include Photon Fund and Berkeley Catalyst Fund.